Insiders · Profile

ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER at GERON · EVP, CHIEF FINANCIAL OFFICER at Editas Medicine. Filing since 12 Jan 2021. CIK 0001755098

GERN GERON CORP EVP, CHIEF FINANCIAL OFFICER · 1 trade EDIT Editas Medicine, Inc. EVP, CHIEF FINANCIAL OFFICER · 12 trades

Company

Date

Role

Action

Shares

Amount

Of holding

GERN GERON CORP

18 Feb 2026

EVP, CHIEF FINANCIAL OFFICER

Sold at will

9,855

$19.12K

35.8%

EDIT Editas Medicine, Inc.

11 May 2023

EVP, CHIEF FINANCIAL OFFICER

Sold on a plan

949

$9.37K

0.9%

EDIT Editas Medicine, Inc.

3 Mar 2023

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

184

$1.64K

0.2%

EDIT Editas Medicine, Inc.

13 Feb 2023

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

4,287

$41.44K

5.3%

EDIT Editas Medicine, Inc.

10 Jan 2023

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

1,752

$14.30K

2.1%

EDIT Editas Medicine, Inc.

5 Dec 2022

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

193

$1.97K

0.2%

EDIT Editas Medicine, Inc.

6 Sep 2022

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

192

$2.88K

0.2%

EDIT Editas Medicine, Inc.

3 Jun 2022

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

1,527

$17.62K

1.8%

EDIT Editas Medicine, Inc.

3 Mar 2022

EVP, CHIEF FINANCIAL OFFICER

Sold, plan not stated

767

$13.29K

0.9%

EDIT Editas Medicine, Inc.

11 Jan 2022

Chief Financial Officer

Sold, plan not stated

1,744

$44.82K

5.3%

EDIT Editas Medicine, Inc.

9 Aug 2021

Chief Financial Officer

Sold, plan not stated

2,500

$150.00K

8.0%

EDIT Editas Medicine, Inc.

28 Jun 2021

Chief Financial Officer

Sold, plan not stated

2,500

$125.00K

8.0%

EDIT Editas Medicine, Inc.

12 Jan 2021

Chief Financial Officer

Sold, plan not stated

1,568

$122.73K

7.8%

13 decisions on file.